Stephen Dale
Chief Tech/Sci/R&D Officer chez KURA ONCOLOGY, INC.
Fortune : 827 967 $ au 31/03/2024
Profil
Stephen Dale is currently the Chief Medical Officer at Kura Oncology, Inc. He previously worked at AstraZeneca PLC as the Global Clinical VP & Clinical Head-Oncology from 2006 to 2015, and as the Global Clinical Vice President.
He then worked at Kyowa Kirin Ltd.
as the Senior VP & Global Head-Medical Science from 2015 to 2020.
Dr. Dale received a doctorate degree from Manchester Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KURA ONCOLOGY, INC.
0,05% | 30/01/2024 | 38 817 ( 0,05% ) | 827 967 $ | 31/03/2024 |
Postes actifs de Stephen Dale
| Sociétés | Poste | Début |
|---|---|---|
| KURA ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 25/08/2020 |
Anciens postes connus de Stephen Dale
| Sociétés | Poste | Fin |
|---|---|---|
Kyowa Kirin Ltd.
 Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the private company is based in London, UK. | Corporate Officer/Principal | 01/08/2020 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/09/2015 |
Formation de Stephen Dale
| Manchester Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the private company is based in London, UK. | Health Technology |
